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Abstract
Background: To develop a sensitive and specific screening tool for knee and hip osteoarthritis in
the general population of elderly people.
Methods: The Knee and Hip OsteoArthritis Screening Questionnaire (KHOA-SQ) was developed
based on previous studies and observed data and sent to 11,002 people aged 60 to 90 years,
stratified by age and gender, who were selected by random sampling. Algorithms of the KHOA-SQ
were created. Respondents positive for knee or hip OA on the KHOA-SQ were invited to be
evaluated by an orthopedic surgeon. A sample of 300 individuals negative for knee or hip OA on
the KHOA-SQ were also invited for evaluation. Sensitivity and specificity were determined for the
KHOA-SQ, as well as for KHOA-SQ questions. Classification and Regression Tree analysis was
used to find alternative screening algorithms from the questionnaire.
Results: Of 11,002 individuals contacted, 7,577 completed the KHOA-SQ. Of 1,115 positive for
knee OA, on the KHOA-SQ, 710 (63.6%) were diagnosed with it. For hip OA, 339 of the 772 who
screened positive (43.9%) were diagnosed it. Sensitivity for the hip algorithm was 87.4% and
specificity 59.8%; for the knee, sensitivity was 94.5% and specificity 43.8%. Two alternative
algorithms provided lower specificity.
Conclusion: The KHOA-SQ offers high sensitivity and moderate specificity. Although this tool
correctly identifies individuals with knee or hip OA, the high false positive rate could pose
problems. Based on our questions, no better algorithm was found.
Background
Osteoarthritis (OA) of the hip and knee are common con-
ditions that, in many cases, necessitate frequent follow-
up, medical therapy, and potentially costly treatments,
such as joint replacement surgery [1]. Nevertheless, rela-
tively little is known about the prevalence of these pathol-
ogies in the general population [2]. Estimating prevalence
requires tools that allow investigators to screen a large
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sample drawn from the general population to identify
those individuals most likely to have the disease [3]. This
can be a blood test, imaging modality, or other simple
assay. None of these are yet available for hip or knee OA,
although the search is underway for such tools [4,5]. Cur-
rently, investigators interested in determining the preva-
lence of hip or knee OA must rely on medical histories or
descriptions of symptoms to identify individuals most
likely to have the disease. Given that no single symptom
can identify patients with hip or knee OA [6], the most rel-
evant ones are often combined to construct an algorithm
that ideally have high specificity and reasonable sensitiv-
ity [7]. Individuals identified by such screening tools as
likely candidates must then undergo further evaluation so
a definitive diagnosis can be made. Only the clinical eval-
uation of a patient with symptoms of knee or hip OA by
an experienced physician and an x-ray of the joint can pro-
vide a definitive diagnosis.
We developed the Knee and Hip OsteoArthritis Screening
Questionnaire (KHOA-SQ) as a possible tool for gauging
the prevalence of hip and knee OA in a general population
study.
Methods
The study was conducted between April 2002 and Decem-
ber 2003 in the province of Vizcaya (Basque Country) in
the north of Spain. Vizcaya has a population of 1,125,000
inhabitants, 23.6% of whom were aged 60 years or older.
The province of Vizcaya is predominantly urban.
Recruitment
To recruit participants from the general population, we
used the register of the Basque Department of Health. This
register includes all people covered by the National
Health System which, in the Basque Country, covers
almost 100% of the population. From that register, we
performed a stratified random sampling by gender and
age (3 categories: 60 to 69, 70 to 79, and 80 to 90 years)
of all adults over sixty in the province.
Based upon a prevalence of 10% for knee OA and of 5%
for hip OA observed in previous studies for patients aged
60 years or older [8-13], and using α = 0.05, 1-β = 0.8, and
an error in the prevalence of OA of less than ± 1.5%, we
estimated that we would need to recruit more than 7,000
individuals. Estimating a 10% exclusion rate and a partic-
ipation rate of at least 70%, we planned to include at least
11,000 individuals in our study.
Selection criteria included: age ≥60 years, resident of Viz-
caya, ability to complete the questionnaire and give con-
sent to participate in the study, and ability to attend an
outpatient clinic. We excluded individuals who were
younger than 60 years, who lived outside the province,
who did not have valid postal addresses or telephone
numbers, who had severe psychiatric, sensorial or physi-
cal illness, or language problems that made it difficult to
complete the questionnaire, or who were unable to attend
the outpatient clinic.
KHOA-SQ development
The KHOA-SQ was created to be a short, quickly com-
pleted questionnaire that included all relevant variables
that alone or in combination would indicate, with a high
sensitivity and specificity, possible OA of the knee or hip.
To create the KHOA-SQ, we reviewed the available litera-
ture to determine if similar tools existed [3,9-12] and
selected from prior studies the variables most likely to
identify patients with knee or hip OA.
The resulting questionnaire had 28 questions in three sec-
tions: 11 pertaining to knee osteoarthritis, 11 to hip oste-
oarthritis, and 6 common or general questions about both
joints related to previous fractures, future interventions,
and sociodemographic data. We conducted a pilot study
with 400 patients undergoing urography or barium
enema examinations to test which combination of ques-
tions offered the best balance of sensitivity and specificity
for hip OA. The algorithms selected are presented in Fig-
ure 1. For the hip screening algorithm (algorithm #1, hip),
we included 4 of the 11 original questions : "During the
last 12 months, have you often had pain in one or both
your hips for one month or more?"; "Has a doctor ever
told you that you have osteoarthritis in one or both of
your hips?"; "Do you have a prosthesis in one or both of
your hips?"; and, "During the last 12 months, have you
had frequent limitations or difficulties walking more than
4 blocks (500 m) because of pain or stiffness in one or
both of your hips?"
For the knee screening algorithm (algorithm #1, knee), we
also included 4 of the original 11 questions: "During the
last 12 months, have you often had pain in one or both
your knees for one month or more?"; "Has a doctor ever
told you that you have osteoarthritis in one or both of
your knees?"; "During the last 12 months, have you had
any limitations rising from a chair or toilet because of
pain or stiffness in one or both of your knees?"; and "Dur-
ing the last 12 months, have you had stiffness in one or
both your knees for one month or more?" We based our
election on previous studies [13].
In both cases, we created algorithms based on the previ-
ous questions to achieve the best possible sensitivity,
while preserving reasonable specificity and positive pre-
dictive value (PPV). PPV positive was defined as OA real
cases among those screening positive. Negative predictive
value (NPV) is defined as no OA real cases among those
screening negative. Sensitivity was defined as percentageBMC Musculoskeletal Disorders 2007, 8:84 http://www.biomedcentral.com/1471-2474/8/84
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of OA cases who screened positive, specificity as percent-
age of non-OA subjects who screened negative and accu-
racy as the percentage of screening results, both positive
and negative, that were correct.
Data collection
Letters were sent to 11,002 randomly selected residents of
Vizcaya province to invite them to participate in the study.
The letter presented the goals of the study, invited the
recipient to participate, and asked for their informed con-
sent. It also included the screening questionnaire for knee
or hip OA along with a stamped return envelope. A
reminder letter was sent to those who had not replied after
15 days. After 30 days, a copy of the questionnaire was
sent to those who had not responded. Finally, we con-
tacted by telephone those who had not responded within
45 days of the initial mailing.
We applied the algorithm to those who answered the
KHOA-SQ. Individuals identified by the questionnaire as
likely to have knee or hip OA were contacted by mail (up
to three times, if necessary) or telephone to invite them to
be evaluated for osteoarthritis at one of three hospitals
chosen to provide ready access to the bulk of the popula-
tion, and thus facilitate participation. Three orthopedic
surgeons who collaborated in the study evaluated partici-
KHOA-SQ screening algorithms by articulation Figure 1
KHOA-SQ screening algorithms by articulation. Complete question is indicated in each square by the number of the question 
(Q#) of Tables 2 (knee) and 3 (hip) respectively.
General HIP Screening Algorithm
NO
NO NO
NO NO
YES
YES
YES YES
YES
Negative Hip Osteo-Arthritis (OA)
Negative Hip OA Positive Hip OA
Q6c. Limitations walking
>4 blocks(500m)
Q2.Physician said pt has arthrosis
or Q3. pt had hip prosthesis
Negative Hip OA Positive Hip OA
Q2. Physician said pt has arthrosis
or Q3. pt had hip prosthesis
Positive Hip OA
Q6c. Limitations walking
>4 blocks(500m)
Q1. Hip Pain
during last 12 months
General KNEE Screening Algorithm
NO YES
NO YES NO YES
NO YES NO YES
NO YES
Negative Knee OA
Negative Knee OA Positive Knee OA
Q5. Knee Stiffness
during last 12 months
Q6a. Limitation when
getting up
Negative Knee OA
Negative Knee OA Positive Knee OA
Q5. Knee Stiffness
during last 12 months
Q6a. Limitation when
getting up
Positive Knee OA
Q2. Physician said pt has arthrosis
Q1. Knee Pain
during last 12 monthsBMC Musculoskeletal Disorders 2007, 8:84 http://www.biomedcentral.com/1471-2474/8/84
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pants at any of the hospitals' outpatient clinics. These sur-
geons were trained by the research team and provided
with standardized questionnaires requesting sociodemo-
graphic data, comorbidities, and symptoms (pain, stiff-
ness, and functional limitations) and signs related to hip
or knee osteoarthritis, separately. Information from a full
clinical examination of the hip, knee, and lower back was
also recorded. If the clinical examination was suggestive of
hip or knee disease and the patient had not undergone an
x-ray within the preceding 6 months, study participants
were invited to have an x-ray of the affected joint(s). All x-
rays were evaluated by the Kellgren and Lawrence [14]
scale for hip OA and the Ahlbäck [15] scale for knee OA.
Each orthopedic surgeon provided a final diagnosis about
the presence or absence of OA. We classified individuals
as having knee or hip OA if they had symptoms and radi-
ographic evidence of OA in either of the hip or knee artic-
ulations. Patients also completed the Western Ontario
and McMaster Universities Osteoarthritis Index
(WOMAC) questionnaire[16,17].
We also included in the evaluation by the orthopaedic
surgeons of some individuals who were negative for knee
or hip OA on the KHOA-SQ. We randomly selected 300
individuals whose screening questionnaires were negative
for both joints. Of these, 158 accepted and were reviewed
by an orthopedic surgeon. Since the orthopedic surgeon
evaluated all 4 joints for each participant, we included in
the estimations those who screened negative for one part
of the questionnaire (hip or knee joint) but were positive
for the other. In all cases the orthopedic surgeons were
blinded to the study goals and the results of the screening
algorithm.
The study was approved by the hospitals Research Com-
mittees. All data were kept confidential.
Statistical analysis
The unit of analysis was the person that was classified as
positive OA for hip whenever any of his hips were positive
and negative otherwise; or positive OA for knee whenever
any of the knees were positive and negative otherwise. Fre-
quencies and percentages were calculated as descriptive
statistics of the sample. Hip and knee OA were treated sep-
arately.
In order to evaluate the possible presence of selection
bias, we compared the answers on symptoms (see tables)
to our screening questionnaire, by joint, between people
who finally went, and those who did not, to the evalua-
tion by the orthopaedic surgeon.
Evaluation of the KHOA-SQ
Selected OA screening algorithms for hip and knee were
evaluated using sensitivity, specificity, and odds ratio by
age and gender. For all of these estimates, 95% confidence
intervals were calculated. Logistic regression models in
which the dependent variable was the final diagnosis of
kip or knee OA were used to estimate the c statistics of
each question or algorithm, which were the independent
variable in each model. In these analyses, the c statistic is
a mathematical function of the sensitivity and specificity
of our tool in classifying patients by means of a logistic
regression model as either having OA or not. The c statistic
is calculated as the fraction of patients with the outcome
among pairs of patients where one has the outcome and
one not, the patient with the highest prediction being
classified as the one with the outcome (or c statistic esti-
mate = .5 (1+Somer's D test). The null value for the C sta-
tistic is 0.5, with a maximum value of 1.0 (higher values
indicating better).
Additionally, and as a way to provide with more informa-
tion on the validity of our tool, we evaluated the KHOA-
SQ results in relation to the WOMAC scores, by reported
problems of hip and knee separately, only in those people
who went to the revision by the orthopaedic surgeon and
who completed the WOMAC. With those previous condi-
tions, we were able to analyze 632 people who presented
hip problems and 953 with knee problems. Means and
standard deviations are provided. A Student t test was per-
formed among those which gave positive for osteoarthri-
tis, according to our KHOA-SQ, and those who did not.
Alternative screening algorithms to the KHOA-SQ were
selected based on their sensitivity, specificity, positive pre-
dictive value, accuracy and odds ratio (OR: being OR the
odds of having an OA). First, the association between
individual questionnaire items and hip or knee OA was
determined. Second, two alternative screening algorithms
for hip and knee OA were created based on the ability of
individual questions to predict OA. The simplest algo-
rithm was based on two items, pain and previous OA sta-
tus reported by any physician (algorithm #2). Another
was based on three items related to OA symptoms – pain,
stiffness, and the ability to walk more than 4 blocks (algo-
rithm #3). Both were evaluated for hip and knee OA in the
same sample.
Finally, we used Classification and Regression Tree
(CART) analysis [18] to find the most informative way to
classify subjects by their response to questionnaire items
into successively more homogeneous groups with regard
to symptomatic knee and hip OA. All the questions
related to main symptoms (pain, stiffness, functional lim-
itation, and insecurity [only for the knee]) and previous
OA status reported by any physician were selected from
the original questionnaire to find the optimal classifica-
tion tree. Two different approaches of decision cost matrix
were considered in the CART analysis. One penalizedBMC Musculoskeletal Disorders 2007, 8:84 http://www.biomedcentral.com/1471-2474/8/84
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equally a false negative and a false positive, and the other
penalized a false negative twice as much as a false positive.
An optimal tree was created for hip OA with only pain and
previous OA status reported by any physician, whereas for
knee OA the items selected were limitation when going
down steps or rising from a chair, previous OA status
reported by any physician, and stiffness. Greater consist-
ency between sensitivity and specificity was found when
false negatives and false positives were penalized equally.
All effects were considered significant at p < 0.05 unless
otherwise noted. Main statistical analyses were performed
using SAS for Windows statistical software, version 8.2.
(SAS Institute, Inc., Carey, NC). CART analysis was per-
formed using CART with S-Plus software [19].
Results
Of the 11,002 randomly selected residents, 852 were
excluded. Of the 10,150 finally included in the study,
2,326 did not return the KHOA-SQ after 3 mailed requests
and a telephone contact, 177 explicitly refused to partici-
pate, and 70 provided information about a relative or
other individual (Figure 2). The final participation rate
was 74.65%.
The mean age of respondents was 71 years; 56.3% were
women (Table 1). A total of 3,168 (41.8%) had KHOA-
SQ results indicative for hip or knee OA, or both; knee OA
was more common than hip OA. Of the 7,577 individuals
who answered the KHOA-SQ, 1,115 of 2,538 with results
indicative of knee OA were reviewed by an orthopedic sur-
geon. Of these, 710 (63.6%) were considered to have knee
OA. With regard to hip OA, 772 of 1,708 respondents
whose KHOA-SQ results were indicative of hip OA were
reviewed by an orthopedic surgeon. Of these, 339
(43.9%) were considered to have hip OA (Figure 2). On
the comparison to the answers on symptoms (those of
tables 2 and 3) to our screening questionnaire, by joint,
between people who finally went, and those who did not,
to the evaluation by the orthopaedic surgeon we found
that there were no statistically significant differences
between both groups on presence of symptoms.
Of the final sample of 1,464, including those positive and
negative to the KHOA-SQ, from whom we have informa-
tion about the definite diagnosis, 934 were women and
530 men; 840 were between the ages of 60 and 69, 525
were between 70 and 79, and 99 were aged 80 years or
older.
We analyzed all relevant individual variables included in
the KHOA-SQ to identify associations with a final diagno-
sis of OA. For knee OA, the questions with the highest spe-
cificity were " Has a doctor ever told you that you have
osteoarthritis in one or both of your knees?" (99.5%),
"Have you had any surgical intervention in one or both of
your knees" (94.1%), and " During the last 12 months,
have you had stiffness in one or both your knees for one
month or more?" (67.9%). The questions with the highest
sensitivity were "During the last 12 months, have you
often had pain in one or both your knees for one month
or more?" (94.8%), and " During the last 12 months, have
you had any limitations going up (85.4%) or down (88%)
stairs because of pain or stiffness in one or both of your
knees?" (Table 2).
For hip OA, the questions with the highest specificity were
" Do you have a prosthesis in one or both of your hips?"
(99.3%), " Have you ever had any surgical intervention in
one or both of your hips?" (98.9%), and "During the last
12 months, have you often had pain in one or both your
hips for one month or more?" (78.5%) (Table 3). The
questions with the highest sensitivity were "During the
last 12 months, have you often had pain in one or both
your hips for one month or more?" (87.1%), followed by
" During the last 12 months, have you had any limitations
on your stockings or shoes because of pain or stiffness in
one or both of your hips?" (72.8%).
In relation to the study of the correlation of our KHOA-SQ
with the WOMAC, the results were as follows. For people
who, according to the KHOA-SQ, did not seem to have
problems of OA in anyone of their hips the mean score in
the 3 WOMAC domains (pain, stiffness, and functional
limitation) measured by the WOMAC were, respectively,
25.1 (18), 23.9 (22.2) and 25 (19.8), whereas for those
that, according to the KHOA-SQ, may suffer of OA the
means were 38.5 (20.5), 37.7 (24.6) and 40 (20.1) respec-
tively in the WOMAC domains. In the case of the knee, the
means were 19.1 (15.8), 21. 4 (22.3), and 23.2 (21.7) for
those who did not seem to have OA problems; whereas in
the case of those who were suggestive to suffer OA prob-
lems the means were, respectively, 36.5 (19.7), 35 (25),
and 38.2 (20.8). In all the cases, the differences between
those which were positive for OA, according to our
KHOA-SQ, and those who were not, were statistically sig-
nificant with p < 0.001 in all the conducted comparisons.
The knee OA screening algorithm we developed had a sen-
sitivity of 94.5%, a specificity of 43.2%, a positive predic-
tive value (PPV) of 63.7%, a negative predictive value
(NPV) of 88.3%, an accuracy of 69.5%, and a c statistic of
0.69. The hip OA screening algorithm had a sensitivity of
87.4%, a specificity of 59.8%, a PPV of 43.9%, an NPV of
92.9%, an accuracy of 67.1%, and a c statistic of 0.74. We
examined the effect of age and gender on these metrics
(Table 4). For the knee OA algorithm, sensitivity and spe-
cificity were similar in all age classes except for men aged
80 and older, in whom the specificity dropped considera-
bly. Differences by gender were minor. For the hip OABMC Musculoskeletal Disorders 2007, 8:84 http://www.biomedcentral.com/1471-2474/8/84
Page 6 of 13
(page number not for citation purposes)
Patient selection process: number of patients included and excluded from the original sample Figure 2
Patient selection process: number of patients included and excluded from the original sample.
People Selection Process
- Address unknown or absent: 499
- Death: 135
- Live outside our area: 42
- Severe physical or mental disease:123
- Not able to fulfill questionnaire: 17
- Younger < 60 years: 8
- Older than 80 years with severe
mobility problems (not able to attend the
consult): 28
852 Excluded
7,577 Answers
- Questionnaire not returned: 2.326
- Refuse to answer: 177
- Data from other person: 70
2,573 Non Respondent
10,150 Included
People selected. Total sample
N=11,002
A.Knee Osteoarthritis evaluation
KHOA-SQ results
Revision by orthopedic surgeon?
Not Revised by OS
n=4,690
308 Negative 41 Positive
Revised by OS
n=349
5,039 Negative
Not Revised by OS
n=1,423
405 Negative 710 Positive
Revised by OS
n=1,115
2,538 Positive
7,577 answers
B. Hip Osteoarthritis evaluation
Revision by orthopedic surgeon?
KHOA-SQ Results
Not Revised by OS
n=5,177
643 Negative 49 Positive
Revised by OS
n=692
5,869 Negative
Not Revised by OS
n=936
433 Negative 339 Positive
Revised by OS
n=772
1,708 Positive
7,577 answersBMC Musculoskeletal Disorders 2007, 8:84 http://www.biomedcentral.com/1471-2474/8/84
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algorithm, sensitivity and specificity were again similar by
age, except among older men, in whom the sensitivity
dropped moderately. The sensitivity was slightly better for
women, while the specificity was better for men.
Since the construction of our negative rows for the calcu-
lations of the sensitivity and specificity came from differ-
ent sources (those evaluated as negatives and that had
reported negative both of the screening algorithms (hip/
knee) and those evaluated as negatives and that had
reported negative to one of the screening algorithms (hip
or knee)) we studied the presence of some bias. In both
joints, the analysis between those evaluated as negatives
and that had reported negative both of the screening algo-
rithms (hip/knee) versus those who were negative to the
explored joint but not the other on relation to the final
diagnosis of osteoarthritis showed not statistically signifi-
cant differences in both joints for those groups.
We examined whether alternative algorithms could
achieve better sensitivity or specificity. None of those eval-
uated (algorithms #2 and 3), offered improved sensitivity
or specificity. We also used the CART analysis to select
additional algorithm trees for knee or hip OA. In the case
of hip OA, the single question "During the last 12
months, have you often had pain in one or both your hips
for one month or more?" had a reasonable good sensitiv-
ity (87.1%) though a relatively low specificity (54.9%). A
simple algorithm that included only two questions about
the presence of pain and a diagnosis of OA by a physician)
provided similar sensitivity (87.1%) and specificity
(54.5%) (Figure 3). The CART knee algorithm provided
with a better specificity (62.8%) and worse sensitivity
(82.1%) than our algorithm (Algorithm #1), and
included 4 variables in a more complex algorithm.
Discussion
In the absence of a simple screening test for knee or hip
OA [20], determining the prevalence in a general popula-
tion is difficult. Basically, the symptoms referred by the
patient are the key issue to screening. We developed a
screening questionnaire for identifying individuals with
knee or hip OA with high sensitivity and moderate specif-
icity.
Accurate data on the prevalence and severity of knee and
hip OA in the general population are needed for a variety
of reasons. In many cases, patients present with severe
pain and functional limitation of the affected joint, which
often translates into a diminished quality of life [21].
Accurate prevalence data can help health care systems
allocate resources for the costly medical and surgical care,
as well as rehabilitation programs, needed to manage and
treat patients with knee and hip OA [13,22,23].
Our study is not the first to attempt to ascertain the symp-
toms most likely to identify individuals with knee or hip
OA [3,9-12,24]. However, to the best of our knowledge it
is the first to evaluate different algorithms of symptoms
for both joints together. Several simple or complex algo-
rithms have been developed to screen for knee OA
[3,10,12,24] or hip OA [9,11] in the general population.
In fact, we based the selection of variables for our KHOA-
SQ on findings of these studies. In the case of hip OA,
prior investigators had suggested "During the last 12
months, have you often had pain in one or both your hips
for one month or more?" as the unique question to iden-
tify individuals with this condition [9]. We found that this
single question has good sensitivity, though low specifi-
city. Screening for knee OA appears to be more complex,
as we and others [3] have shown. The question "During
the last 12 months, have you often had pain in one or
both your knees for one month or more?" was not nearly
as sensitive as was the corresponding question about hip
pain. A selection of the most predictive questions by CART
analysis provided a stronger algorithm, though a more
complex one that was far from perfect.
Studies on the prevalence of knee and hip OA have been
conducted in all parts of the world, including the UK [9-
Table 1: Characteristics of individuals who answered the KHOA-SQ (n = 7577)a
Total Hip Knee
Age:   (DE) 70.96 (6.96)
<70 3730 (49.23)
70–79 2886 (38.09)
≥ 80 961 (12.68)
Gender:
Male (%) 3313 (43.72)
Female (%) 4264 (56.28)
KHOA-SQ screening positive: n 
(%)
3168 (41.81) 1708 (22.54) 2538 (33.50)
a Percentages were calculated based on non missing answers.
KHOA-SQ = Knee and Hip OsteoArthritis Screening Questionnaire
xBMC Musculoskeletal Disorders 2007, 8:84 http://www.biomedcentral.com/1471-2474/8/84
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Table 2: Rate of response and association of responses to individual questions about knee OA with symptomatic knee osteoarthritis (n 
= 1464)
Question n Frequency of 
positive 
findings, %
Sensitivity,% 
(95% CI)
Specificity,% 
(95% CI)
Positive 
Predictive 
Value,% (95% 
CI)
Negative 
Predictive 
Value,% (95% 
CI)
Odds ratio 
(95% CI)
C statistics
1. – During the 
last 12 months, 
have you often 
had pain in one 
or both your 
knees for one 
month or 
more?
1413 80.96 94.77 (93.17, 
96.37)
34.48 (30.87, 
38.09)
61.80 (58.98, 
64.62)
85.50 (81.29, 
89.71)
9.54 (9.66, 
13.67)
0.646
2. – Has a 
doctor ever 
told you that 
you have 
osteoarthritis 
in one or both 
of your knees?
1419 62.86 80.70 
(77.87,83.53)
56.91 (53.17, 
60.65)
67.49 (64.42, 
70.56)
72.68 (68.88, 
76.48)
5.52 (4.35, 
7.00)
0.688
3. – Do you 
have a 
prosthesis in 
one or both of 
your knees?
1414 3.75 6.76 (4.95, 
8.57)
99.55 
(99.04,100.1)
94.34 (88.12, 
100.6)
49.30 (46.64, 
51.96)
16.21 (5.03, 
52.21)
0.532
4. – Have you 
had any 
surgical 
intervention in 
one or both of 
your knees?
1415 11.38 16.40 (13.73, 
19.07)
94.09 (92.31, 
95.87)
75.16 (68.49, 
81.83)
50.80 (48.03, 
53.57)
3.12 (2.15, 
4.54)
0.552
5. – During the 
last 12 months, 
have you had 
stiffness in one 
or both your 
knees for one 
month or 
more?
1417 48.98 64.37 (60.92, 
67.82)
67.90 (64.38, 
71.42)
68.73 (65.28, 
72.18)
63.49 (59.98, 
67.00)
3.82 (3.07, 
4.77)
0.661
6. – During the 
last 12 months, 
have you had 
any of the 
following 
limitations 
because of pain 
or stiffness in 
one or both of 
your knees?
6 a. – 
Rising from 
a chair or 
toilet
1360 61.91 78.58 (75.58, 
81.58)
56.79 (52.96, 
60.62)
67.10 (63.93, 
70.27)
70.27 (66.33, 
74.21)
4.82 (30.80 
6.11)
0.677
6 b. – 
Going up 
steps
1380 69.71 85.44 (82.88, 
88.00)
47.85 (44.02, 
51.68)
64.66 (61.64, 
67.68)
74.64 (70.47, 
78.81)
5.38 (4.16, 
6.96)
0.666
6 c. – 
Going 
down steps
1374 70.74 88.05 (85.69, 
90.41)
48.76 (44.91, 
52.61)
65.95 (62.97, 
68.93)
78.36 (74.33, 
82.39)
7.01 (5.34, 
9.20)
0.684
6d. – 
Walking 4 
blocks (or 
500 m)
1348 55.34 70.72 (67.37, 
74.07)
61.62 (57.86, 
65.38)
67.02 (63.65, 
70.39)
65.61 (61.82, 
69.40)
3.88 (3.09, 
4.87)
0.662
7. – During the 
last 12 months, 
have you often 
experienced 
any sensation 
of insecurity or 
that one or 
both of your 
knees failed?
1394 62.55 77.05 (74.00, 
80.10)
53.47 (49.67, 
57.27)
64.68 (61.51, 
67.85)
67.82 (63.81, 
71.83)
3.86 (3.07, 
4.86)
0.653
95% CI = 95% confidence interval
c statistics: estimated by logistic regression modelBMC Musculoskeletal Disorders 2007, 8:84 http://www.biomedcentral.com/1471-2474/8/84
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Table 3: Rate of response and association of responses to individual questions about hip OA with symptomatic hip osteoarthritis (n = 
1464)
Question n Frequency of 
positive 
findings,%
Sensitivity,% 
(95% CI)
Specificity,% 
(95% CI)
Positive 
Predictive 
Value,% (95% 
CI)
Negative 
Predictive 
Value,% (95% 
CI)
Odds ratio 
(95% CI)
C statistics
1. – During 
the last 12 
months, have 
you often had 
pain in one or 
both your 
hips for one 
month or 
more?
1316 56.69 87.09 (83.65, 
90.53)
54.94 (51.78, 
58.10)
42.49 (38.94, 
46.04)
91.75 (89.49, 
94.01)
8.22 (5.90, 
11.46)
0.712
2. – Has a 
doctor ever 
told you that 
you have 
osteoarthritis 
in one or both 
of your hips?
1357 40.01 66.67 (61.92, 
71.42)
70.28 (67.42, 
73.14)
46.41 (42.22, 
50.60)
84.52 (82.04, 
87.00)
4.73 (3.67, 
6.10)
0.685
3. – Do you 
have a 
prosthesis in 
one or both 
of your hips?
1362 4.92 16.04 (12.32, 
19.76)
99.29 (98.77, 
99.81)
89.55 (82.23, 
96.87)
75.75 (73.42, 
78.08)
26.78 (12.12, 
59.19)
0.577
4. – Have you 
ever had any 
surgical 
intervention 
in one or both 
of your hips?
1366 3.07 8.22 (5.45, 
10.99)
98.89 (98.24, 
99.54)
73.81 (60.50, 
87.12)
73.87 (71.50, 
76.24)
7.97 (3.96, 
16.02)
0.536
5. – During 
the last 12 
months, have 
you had 
stiffness in 
one or both 
of your hips 
for one 
month or 
more?
1352 28.48 47.03 (41.94, 
52.12)
78.51 (75.94, 
81.08)
45.19 (40.22, 
50.16)
79.73 (77.20, 
82.26)
3.24 (2.51, 
4.18)
0.628
6. – During 
the last 12 
months, have 
you had any of 
the following 
limitations 
because of 
pain or 
stiffness in 
one or both 
of your hips?
6.a. – 
Rising from 
a chair or 
toilet.
1331 45.98 69.92 (65.24, 
74.60)
63.20 (60.15, 
66.25)
42.16 (38.25, 
46.07)
84.56 (81.92, 
87.20)
3.99 (3.08, 
5.17)
0.666
6 b. – 
Putting on 
your 
stockings 
or shoes.
1336 47.68 72.85 (68.33, 
77.37)
62.03 (58.97, 
65.09)
42.54 (38.70, 
46.38)
85.55 (82.94, 
88.16)
4.38 (3.37, 
5.70)
0.674
6 c. – 
Walking 4 
blocks (or 
500 m)
1326 42.76 69.11 (64.40, 
73.82)
67.40 (64.43, 
70.37)
44.97 (40.88, 
49.06)
84.98 (82.44, 
87.52)
4.62 (3.57, 
5.99)
0.683
95% CI = 95% confidence interval
c statistics: estimated by logistic regression modelBMC Musculoskeletal Disorders 2007, 8:84 http://www.biomedcentral.com/1471-2474/8/84
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12,24], the US [3,25], Canada [13], Europe (specifically
Sweden, Denmark, Iceland, Netherlands, and Italy) [26-
30], Australia [31], China [32,33], and Saudi Arabia [34].
In most of these studies, screening – when it was con-
Table 4: Sensitivity, specificity and odds ratios (OR) of the screening questionnaire for knee or hip osteoarthritis by gender and age
Sensitivity,% (95% CI) Specificity,% (95% CI) OR (95% CI)
Hip Total 87.37% (85.03, 89.71) 59.76% (56.11, 63.41) 10.27 (7.43, 14.19)
Men: < 70 86.11% (78.12, 94.10) 67.65% (61.71, 73.59) 12.96 (6.30, 26.66)
70–79 83.02% (72.91, 93.13) 62.86% (54.86, 70.86) 8.27 (3.74, 18.32)
≥ 80 75.00% (50.50, 99.50) 73.33% (50.95, 95.71) 8.25 (1.45, 46.86)
Women: < 70 89.68% (84.37, 94.99) 54.46% (49.60, 59.32) 10.39 (5.67, 19.06)
70–79 90.82% (85.10, 96.54) 57.26% (50.92, 63.60) 13.29 (6.37, 27.58)
≥ 80 81.48% (66.83, 96.13) 64.44% (50.45, 78.43) 7.98 (2.54, 25.11)
Knee Total 94.54% (93.21, 95.87) 43.20% (38.00, 48.40) 13.17 (9.29, 18.65)
Men: < 70 95.83% (92.25, 99.41) 42.11% (35.09, 49.13) 16.73 (6.53, 42.85)
70–79 95.24% (91.17, 99.31) 45.45% (35.05, 55.85) 16.67 (6.18, 44.91)
≥ 80 93.33% (80.70, 100)* 16.67% (0, 37.76)* 2.80 (0.22, 35.29)
Women: < 70 92.51% (89.35, 95.67) 45.63% (39.61, 51.65) 10.36 (6.18, 44.91)
70–79 96.43% (93.83, 99.03) 40.44% (32.19, 48.69) 18.33 (8.01, 41.98)
≥ 80 93.75% (86.90, 100)* 45.83% (25.90, 65.76) 12.69 (3.07, 52.40)
95% CI = 95% confidence interval. *Lower and upper limits have been set up to 0 and 100 when they were negative or greater than 100, 
respectively.
Alternative screening algorithms for each joint Figure 3
Alternative screening algorithms for each joint. In parenthesis 95% confidence intervals. Complete question is indicated in each 
square by the number of the question (Q#) of Tables 2 (knee) and 3 (hip) respectively
1.- Alternative for hip OA screening
n = 1307 patients 
Sensitivity Specificity PPV Accuracy
87.09%
(83.65, 90.53)
54.51%
(51.33, 57.69) 
42.49%
(38.94, 46.04)
63.58%
(60.97, 66.19)
2.- Alternative for knee OA screening 
OA No
No
OA No
No
OA No
No
OA Yes
Yes
Q6a. Limitation when
rising from a chair
Yes
Q5. Presence
of stiffness
No
OA Yes
Yes
Q2. Previous diagnosis
of OA
Yes
Q6c. Limitations when
going down steps
OA No
No
OA Yes
Yes
Q2. Previous diagnosis
of OA
No
OA Yes
Yes
Q1. Pain in the
hip
n = 1353 patients 
Sensitivity Specificity PPV Accuracy
82.13%
(79.34, 84.92)
62.76%
(58.99, 66.53)
71.62%
(68.55, 74.69)
73.10%
(70.74, 75.46) BMC Musculoskeletal Disorders 2007, 8:84 http://www.biomedcentral.com/1471-2474/8/84
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ducted – used a simple question such as "Do you have
pain in a particular joint?" followed by a complete exam-
ination of those reporting such pain by an orthopedic sur-
geon, as was done in our study. In contrast, we employed
more questions in a more complex algorithm to screen for
individuals with knee or hip OA.
The main limitation of our study is missing data. Despite
three mailings and a telephone contact, one-quarter of the
study population did not complete or return the screening
questionnaire. Even so, our response rate (74.65%) was
similar to or better than response rates achieved in previ-
ous studies. Among the respondents identified by the
KHOA-SQ as being positive for knee or hip OA, 55–56%
did not attend an appointment for evaluation by one of
the orthopedic surgeons involved in the study. We aimed
to make these appointments as convenient as possible by
asking the respondent to choose an opportune day and
time, and the surgeons saw patients in clinics that were
accessible by public transportation and that offered a wide
geographic range. Even so, some of the respondents
would have had to travel up to 50 kilometers to be evalu-
ated. Those without a relative or friend to help with trans-
portation may have found this a difficult task. It is
possible that respondents who did not come for evalua-
tion were more likely to have mobility problems due to
OA. This fact may have also biased our estimations of sen-
sitivity and specificity, though, as we have shown, no dif-
ferences were found in the rate of symptoms among
attendants and non attendants.
An additional problem is the composition of the group of
negative result to our screening algorithm that was evalu-
ated by the orthopaedics surgeons. It contained people
who gave negative for both joints and people who gave
negative to the symptoms of the evaluated joint but not to
the other. This may have biased our results. Nevertheless,
the rates of those diagnosed finally as osteoarthritis
between both groups for each joint were not different sta-
tistically.
Another different and important issue is the presence of a
spectrum bias in our study. This comes from the different
rate from negative/positive test between the data found in
the field work (test positive 33% for knee and 22. 5% for
hip- Figure 2) and the configuration of the 2 × 2 table for
the estimation of sensitivity and the specificity. The
number of included for the positive/negative test rows for
the estimation of sensitivity and the specificity did not
respect those percentages (76.2/23.8 for the knee and
52.7/47.3% for the hip respectively). This do have impli-
cations on the estimation of the sensitivity and the specif-
icity, being, possible that the real sensitivity is lower and
higher the specificity.
The performance of the OA evaluations by three different
three orthopedic surgeons may have been another limita-
tion of the study. Differential assessments by each of the
surgeons could have biased the results. However, all three
were trained before the study, were asked to conduct each
examination according to a prepared manual, and com-
pleted a standardized questionnaire to gather identical
information for each patient. For making a definitive diag-
nosis of knee or hip OA, we followed criteria established
by several scientific societies [35,36], based on the
patient's self-reported symptoms and evaluation of an x-
ray. In addition the surgeons were blinded as to the study
goals.
Finally, our study population included only individuals
aged 60 and older, thus our results have no generalizabil-
ity to a younger population.
The screening algorithms we defined have, in general,
acceptable sensitivity but poor specificity. Their low posi-
tive predictive value and the high rate of false positives
have some consequences. With the current estimations of
the sensitivities and specificities of our screening algo-
rithm false positives may outweighing true positives. If
this happens, it may be an important overload for any
sanitary service or may require furtherscreening to avoid
unnecessary exams. In any case, our real rate of positive
tests in this field work was of 33 of and a 22.5% (knee and
hip). From the health system perspective, use of such algo-
rithms would necessitate the evaluation of several patients
without knee or hip OA for each one definitively diag-
nosed with these conditions, something usual on screen-
ing tools. From the patient's point of view, a positive
screening test could be stressful, but given that knee and
hip OA are usually not potentially fatal conditions, the
stress may not be as serious as it would be for a positive
test for lung cancer, for instance.
Conclusion
The development of a screening algorithm for knee or hip
OA that provides adequate sensitivity and specificity is an
important goal for the management of these conditions
[3]. Our algorithm, which with the current results seem to
be sensitive but not highly specific for knee or hip OA, can
be used in screening studies. At the present time, screening
the general population for knee and hip OA must still
depend on assessment of individuals' self-reported symp-
toms followed by clinical evaluation. But given the impor-
tance of learning more about the real prevalence and
impact of knee and hip OA, even imperfect tools such as
the KHOA-SQ have a place in epidemiological studies.
Nevertheless, an important issue for the future would be
to test the KHOA-SQ in other settings with complete data
for those positive and negative to the test.BMC Musculoskeletal Disorders 2007, 8:84 http://www.biomedcentral.com/1471-2474/8/84
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